KIR3DL2 in cutaneous T-cell lymphoma: from a promising biomarker to a potential therapeutic target
Br J Dermatol
.
2020 Jun;182(6):1325-1326.
doi: 10.1111/bjd.18682.
Epub 2019 Dec 5.
Authors
J Sun
1
,
Y Wang
1
Affiliation
1
Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China.
PMID:
31808144
DOI:
10.1111/bjd.18682
No abstract available
Publication types
Comment
MeSH terms
Biomarkers
Humans
Lymphoma, T-Cell, Cutaneous*
Mycosis Fungoides*
Receptors, KIR3DL2
Sezary Syndrome*
Skin Neoplasms*
Substances
Biomarkers
KIR3DL2 protein, human
Receptors, KIR3DL2